一种蛋白质DX (PDX) 类似物,在体外对流感A(H1N1) 病毒具有活性
Nicolas Fortin1, Mathilde Hénaut1, Nathalie Goyette1
1Research Center in Infectious Diseases, CHU de Québec-Université Laval, Quebec City, Canada.
Journal of medical virology
|February 25, 2024
概括
一种新型蛋白质类似物AN-137B显示出强大的抗病毒活性对抗流感A病毒,包括耐药菌株. 这种化合物还表现出抗炎作用和与现有的抗病毒药物具有协同作用的潜力.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药用化学 医学化学
背景情况:
- 目前的流感治疗方法,如oseltamivir和baloxavir,由于耐药性和不受控制的炎症而面临局限性.
- 支持溶解的介质,包括D1 (PD1) 和DX (PDX) 蛋白质,具有抗炎和抗流感的特性.
研究的目的:
- 为了合成简化的protectin DX (PDX) 类似物.
- 评估这些类似物对抗流感A (H1N1) 病毒的体外抗病毒活性,包括耐药菌株.
- 评估与现有的抗病毒药物的抗炎潜力和协同效应.
主要方法:
- 合成PDX类似物.
- 使用ST6GalI-MDCK细胞进行体外抗病毒检测,以确定对敏感和耐药H1N1菌株的IC50值.
- 细胞活力测试 (MTS) 用于计算CC50和选择性指数.
- 通过测量化物产量和iNOS活性,对LPS刺激的巨细胞产生抗炎作用的评估.
- 与奥塞尔塔米维尔和巴洛克萨维尔的联合研究.
主要成果:
- 该PDX模拟AN-137B显示了病毒复制的剂量依赖性降低,IC50值为A/波多黎各/8/1934 (H1N1) 的23.8μM和耐药A(H1N1) pdm09菌株的32.636.7μM.
- 安-137B的选择性指数 (26.8) 是有利的,CC50为638.7μM.
- 当AN-137B与分别oseltamivir和baloxavir结合使用时,观察到体外协同和添加效应.
- 在LPS刺激的巨细胞中,AN-137B降低了酸盐的产生,这表明它具有抗炎活性.
结论:
- 蛋白质类似物AN-137B显示出对抗流感A病毒感染的显著治疗潜力.
- AN-137B的双重抗病毒和抗炎性质,以及其协同作用的潜力,使其成为进一步研究的有希望的候选人.
- 需要在动物模型中进行进一步的临床前评估,以确认AN-137B的疗效.
更多相关视频
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
8.3K
07:15Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity
Published on: November 22, 2021
2.3K
相关概念视频
Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
